About Pediatric And Adult Hemoconcentrators
Hemoconcentrators are medical devices that are used to remove excess fluid from a patient’s vascular system. They are an important component during extracorporeal bypass surgery to control hemodilution and haematocrit. The usages of hemoconcentrators is increasing continuously during cardiac bypass surgery. The hemoconcentrators include adult and pediatric hemoconcentrator. These concentrators include hemocor HPH hemoconcentrator that includes no-rinse hemoconcentrator that allows insertion into the extracorporeal circuit at any time during surgery without the need to rinse the unit. This hemoconcentrators comes with different sizes and glycerine-free polysulfone membranes for excellent biocompatibility. The hemoconcentrators help to reduce the risk after post-operative bleeding and reduce the need for homologous blood and blood products.
Attributes | Details |
---|
Study Period | 2017-2027 |
Base Year | 2021 |
Unit | Value (USD Million) |
CAGR | 3.3% |
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Medivators Inc., Terumo Corporation (Japan), LivaNova (United Kingdom), Maquet (a Getinge Group company) (Germany), Medica S.p.A (Italy), Medtronic (Ireland), ANDOCOR n.v. (Belgium) and Sorin Group (Italy) are some of the key players that are part of study coverage.
Segmentation Overview
AMA Research has segmented the market of Global Pediatric And Adult Hemoconcentrators market by Type (Pediatric Hemoconcentrators and Adult Hemoconcentrators), Application (Hospitals, Ambulatory Surgical Centre and Others) and Region.
On the basis of geography, the market of Pediatric And Adult Hemoconcentrators has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
The U.S. Food and Drug Administration (FDA) regulates and grants approval to hemoconcentrator and the U.S. FDA also recalls products in case of any problem in device. For instance, in 2015, the U.S. Food and Drug Administration recalled Terumo Custom Cardiovascular Procedure Kit X-Coated Adult Pak. The custom cardiovascular procedure kits contain recalled component, Medivators HPH700, the high performance hemoconcentrators.
Market Drivers
- Reduces the need for homologous blood and blood products by providing patients with their own concentrated whole blood
Opportunities
- Growing demand from emerging economies such as China, India, among others
Restraints
- Availability of substitutes for hemoconcentrators
Challenges
- Complications associated with hemoconcentrators
- Lack of expertise
Key Target Audience
Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Hospitals, Government Regulatory and Research Organizations and End-Use Industries
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand companys positioning regarding market value, volume and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.